Centre for Molecular Medicine and Biobanking, Faculty of Medicine and Surgery, University of Malta, Nikolai Paul Pace, Room 325, Msida, 2080, MSD, Malta.
Department of Medicine, Faculty of Medicine and Surgery, University of Malta, Msida, MSD2080, Malta.
Acta Diabetol. 2022 Mar;59(3):339-348. doi: 10.1007/s00592-021-01814-7. Epub 2021 Oct 22.
To investigate the frequency and spectrum of glucokinase (GCK) mutations in a cohort of adults from an island population having a high prevalence of diabetes mellitus (DM).
A single-centre cohort study was conducted, including 145 non-obese adults of Maltese-Caucasian ethnicity with impaired fasting glycaemia (IFG) or non-autoimmune diabetes diagnosed before the age of 40 years. Bidirectional sequencing of the GCK coding regions was performed. Genotype-phenotype associations and familial segregation were explored and the effects of missense variants on protein structure were evaluated using computational analysis.
Three probands with pathogenic/likely pathogenic GCK variants in the heterozygous state having clinical features consistent with GCK-diabetes were detected. The missense variants have structurally destabilising effects on protein structure. GCK variant carriers exhibited a significantly lower body mass index and serum triglyceride levels when compared to GCK variant non-carriers.
The frequency of GCK-diabetes is approximately 2% in non-obese Maltese adults with diabetes or prediabetes. This study broadens the mutational spectrum of GCK and highlights clinical features that could be useful in discriminating GCK-DM from type 2 DM or prediabetes. It reinforces the need for increased molecular testing in young adults with diabetes having a suspected monogenic aetiology.
研究高糖尿病流行岛民群体中成年人群葡萄糖激酶(GCK)突变的频率和谱。
进行了一项单中心队列研究,包括 145 名非肥胖的马耳他-高加索裔成年人,他们患有空腹血糖受损(IFG)或 40 岁以前诊断出的非自身免疫性糖尿病。对 GCK 编码区进行了双向测序。探讨了基因型-表型相关性和家族分离,并使用计算分析评估错义变异对蛋白质结构的影响。
在具有与 GCK 糖尿病一致的临床特征的杂合状态下发现了 3 名有致病性/可能致病性 GCK 变异的先证者。错义变异对蛋白质结构具有结构不稳定的影响。与 GCK 变异非携带者相比,GCK 变异携带者的体重指数和血清甘油三酯水平显著降低。
在患有糖尿病或糖尿病前期的非肥胖马耳他成年人中,GCK 糖尿病的发生率约为 2%。本研究拓宽了 GCK 的突变谱,并强调了有助于区分 GCK-DM 与 2 型糖尿病或糖尿病前期的临床特征。它强调了在疑似单基因病因的年轻成年糖尿病患者中增加分子检测的必要性。